Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell Carcinoma

Acinic cell carcinoma (AcCC) is a morphologically distinctive salivary gland malignancy often associated with chromosome rearrangements leading to overexpression of the NR4A3 transcription factor. However, little is known about how NR4A3 contributes to AcCC biology. Detailed RNA-sequencing of 21 archived AcCC samples revealed fusion reads arising from recurrent t(4;9), t(9;12), t(8;9) or t(2;4) chromosomal translocations, which positioned highly active enhancers adjacent to the promoter of the NR4A3 gene or the closely related NR4A2 gene, resulting in their aberrant overexpression. Transcriptome analyses revealed several distinct subgroups of AcCC tumors, including a subgroup that overexpressed both NR4A3 and MSANTD3. A poor survival subset of the tumors with high-grade transformation expressed NR4A3 and POMC as well as MYB, an oncogene that is the major driver in a different type of salivary gland tumor, adenoid cystic carcinoma. The combination of NR4A3 and MYB showed cooperativity in regulating a distinct set of genes. In addition, the ligand binding domain of NR4A3 directly bound the Myb DNA binding domain. Transformation assays indicated that, while overexpressed NR4A3 was sufficient to generate transformed colonies, the combination of NR4A3 plus Myb was more potent, leading to anchorage-independent growth and increased cellular invasiveness. The results confirm that NR4A3 and NR4A2 are the main driver genes of AcCC and suggest that concurrent overexpression of NR4A3 and MYB defines a subset of AcCC patients with high-grade transformation that display exceptionally poor outcome.

[1]  R. Eils,et al.  Nuclear NR4A2 (Nurr1) Immunostaining is a Novel Marker for Acinic Cell Carcinoma of the Salivary Glands Lacking the Classic NR4A3 (NOR-1) Upregulation. , 2020, The American journal of surgical pathology.

[2]  Yongheng Chen,et al.  Structural basis of NR4A1 bound to the human pituitary proopiomelanocortin gene promoter. , 2019, Biochemical and biophysical research communications.

[3]  R. Eils,et al.  Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands , 2019, The American journal of surgical pathology.

[4]  R. Eils,et al.  Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands , 2019, Nature Communications.

[5]  D. Deschler,et al.  Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland , 2018, JAMA otolaryngology-- head & neck surgery.

[6]  S. Ness,et al.  Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes , 2017, OncoTarget.

[7]  H. Arai,et al.  The Orphan Nuclear Receptor NR4A3 Is Involved in the Function of Dendritic Cells , 2017, The Journal of Immunology.

[8]  S. Ness,et al.  Optimized approach for Ion Proton RNA sequencing reveals details of RNA splicing and editing features of the transcriptome , 2017, PloS one.

[9]  A. Chinnaiyan,et al.  Next generation sequencing of extraskeletal myxoid chondrosarcoma , 2017, Oncotarget.

[10]  R. West,et al.  Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma , 2017, PloS one.

[11]  J. Bishop,et al.  Salivary acinic cell carcinoma: reappraisal and update , 2016, European Archives of Oto-Rhino-Laryngology.

[12]  J. Drouin.  60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression. , 2016, Journal of molecular endocrinology.

[13]  Huining Kang,et al.  Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma. , 2016, Cancer discovery.

[14]  B. Marples,et al.  Novel CARM1-Interacting Protein, DZIP3, Is a Transcriptional Coactivator of Estrogen Receptor-α. , 2015, Molecular endocrinology.

[15]  D. Crean,et al.  Molecular Interactions between NR4A Orphan Nuclear Receptors and NF-κB Are Required for Appropriate Inflammatory Responses and Immune Cell Homeostasis , 2015, Biomolecules.

[16]  H. Ranhotra.  The NR4A orphan nuclear receptors: mediators in metabolism and diseases , 2015, Journal of receptor and signal transduction research.

[17]  Taosheng Chen,et al.  The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer. , 2015, Cellular signalling.

[18]  Rama R. Gullapalli,et al.  Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion. , 2014, Cancer genetics.

[19]  Samuel Singer,et al.  Extraskeletal myxoid chondrosarcoma with non-EWSR1-NR4A3 variant fusions correlate with rhabdoid phenotype and high-grade morphology. , 2014, Human pathology.

[20]  L. G. Moss,et al.  Nkx6.1 regulates islet β-cell proliferation via Nr4a1 and Nr4a3 nuclear receptors , 2014, Proceedings of the National Academy of Sciences.

[21]  Stephen Safe,et al.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets. , 2014, Molecular endocrinology.

[22]  J. Eloy,et al.  Demographic trends and disease‐specific survival in salivary acinic cell carcinoma: An analysis of 1129 cases , 2014, The Laryngoscope.

[23]  K. Gysling,et al.  Nur transcription factors in stress and addiction , 2013, Front. Mol. Neurosci..

[24]  A. Garden,et al.  Prognostic factors associated with decreased survival in patients with acinic cell carcinoma. , 2013, JAMA otolaryngology-- head & neck surgery.

[25]  Weijun Luo,et al.  Pathview: an R/Bioconductor package for pathway-based data integration and visualization , 2013, Bioinform..

[26]  Melissa J. Davis,et al.  Research resource: nuclear receptors as transcriptome: discriminant and prognostic value in breast cancer. , 2013, Molecular endocrinology.

[27]  A. Rogers,et al.  Molecular Pathways: The Role of NR4A Orphan Nuclear Receptors in Cancer , 2012, Clinical Cancer Research.

[28]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[29]  P. Aarnisalo,et al.  Cross-talk between NR4A orphan nuclear receptors and β-catenin signaling pathway in osteoblasts. , 2011, Archives of biochemistry and biophysics.

[30]  F. Cavagnini,et al.  The human POMC gene promoter: Where do we stand? , 2011, Journal of endocrinological investigation.

[31]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[32]  Ricardo Henao,et al.  Molecular signatures of thyroid follicular neoplasia. , 2010, Endocrine-related cancer.

[33]  T. Hasegawa,et al.  Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes. , 2010, Human pathology.

[34]  M. Laakso,et al.  Common polymorphisms within the NR4A3 locus, encoding the orphan nuclear receptor Nor-1, are associated with enhanced β-cell function in non-diabetic subjects , 2009, BMC Medical Genetics.

[35]  M. Konopleva,et al.  HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML , 2013, Leukemia.

[36]  J. Milbrandt,et al.  Abrogation of nuclear receptors Nr4a3 andNr4a1 leads to development of acute myeloid leukemia , 2007, Nature Medicine.

[37]  W. J. Kent,et al.  The UCSC Genome Browser , 2007, Current protocols in bioinformatics.

[38]  Thomas Lengauer,et al.  Improved scoring of functional groups from gene expression data by decorrelating GO graph structure , 2006, Bioinform..

[39]  J. Northrop,et al.  Histone H3 Lysine 9 Methyltransferase G9a Is a Transcriptional Coactivator for Nuclear Receptors* , 2006, Journal of Biological Chemistry.

[40]  Colleen C Nelson,et al.  Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? , 2005, Endocrine reviews.

[41]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Toshihiko Tsukada,et al.  Prostaglandin A2 acts as a transactivator for NOR1 (NR4A3) within the nuclear receptor superfamily. , 2005, Biological & pharmaceutical bulletin.

[43]  N. Bhattacharyya,et al.  Clinical Characteristics and Survival for Major Salivary Gland Malignancies in Children , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[44]  K. S. A. Wansa,et al.  The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine* , 2003, Journal of Biological Chemistry.

[45]  G. Tonon,et al.  t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway , 2003, Nature Genetics.

[46]  J. Drouin,et al.  Dimer-Specific Potentiation of NGFI-B (Nur77) Transcriptional Activity by the Protein Kinase A Pathway and AF-1-Dependent Coactivator Recruitment , 2003, Molecular and Cellular Biology.

[47]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[48]  M. Stallcup,et al.  Synergistic Enhancement of Nuclear Receptor Function by p160 Coactivators and Two Coactivators with Protein Methyltransferase Activities* , 2001, The Journal of Biological Chemistry.

[49]  J. Drouin,et al.  Heterodimerization between Members of the Nur Subfamily of Orphan Nuclear Receptors as a Novel Mechanism for Gene Activation , 1999, Molecular and Cellular Biology.

[50]  D. Ann,et al.  Involvement of Nuclear Orphan Receptor NGFI-B in Transcriptional Activation of Salivary-specific R15 Gene by cAMP* , 1996, The Journal of Biological Chemistry.

[51]  G. Thomas,et al.  Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. , 1995, Human molecular genetics.

[52]  T. Gibson,et al.  Proposed structure for the DNA-binding domain of the Myb oncoprotein based on model building and mutational analysis. , 1991, Protein engineering.

[53]  J. Batsakis,et al.  Salivary Gland Tumors in Children , 1991, The Annals of otology, rhinology, and laryngology.

[54]  J. Batsakis,et al.  Histogenesis of salivary gland neoplasms: a postulate with prognostic implications , 1989, The Journal of Laryngology & Otology.

[55]  Alexander Dobin,et al.  Optimizing RNA-Seq Mapping with STAR. , 2016, Methods in molecular biology.

[56]  P. Neumeister,et al.  The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. , 2015, Current drug targets.

[57]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..